Impact of intravenous lipid emulsions on liver function tests: Contribution of parenteral fish oil

Nutrition

Volumn 31, Issue 9, 2015, Pages 1109-1116

  Badia Tahull, Maria B ^a   Llop Talaveron, Josep ^a   Leiva Badosa, Elisabet ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Cholestasis; Fat emulsions; Intravenous; Parenteral nutrition; 3 fatty acids; 6 fatty acids

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; C REACTIVE PROTEIN; FISH OIL; GAMMA GLUTAMYLTRANSFERASE; INTRAVENOUS LIPID EMULSION; LIGHT CHAIN TRIGLYCERIDE; LIPID EMULSION; MEDIUM CHAIN TRIACYLGLYCEROL; OLIVE OIL; SOYABEAN OIL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VEGETABLE OIL; EDIBLE OIL; PARENTERAL SOLUTION;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; COLORECTAL CANCER; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GASTROESOPHAGEAL CANCER; HOSPITAL PATIENT; HUMAN; INCIDENCE; INFLAMMATORY BOWEL DISEASE; LIPID COMPOSITION; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PANCREAS CANCER; PANCREATITIS; PARENTERAL NUTRITION; PRIORITY JOURNAL; TREATMENT DURATION; ADVERSE EFFECTS; AGED; BLOOD; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECTS; LIVER; METABOLISM;

AGED; ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; BILIRUBIN; DIETARY FATS, UNSATURATED; FAT EMULSIONS, INTRAVENOUS; FEMALE; FISH OILS; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; LIVER; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PARENTERAL NUTRITION; PARENTERAL NUTRITION SOLUTIONS; PLANT OILS;

EID: 84938062158     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2015.04.005     Document Type: Article

References (57)

1. Btaiche I.F., Khalidi N. Metabolic complications of parenteral nutrition in adults, part 2. Am J Health Syst Pharm 2004, 61:2050-2057. quiz 8-9.
2. de Meijer V.E., Gura K.M., Le H.D., Meisel J.A., Puder M. Fish oil-based lipid emulsions prevent and reverse parenteral nutrition-associated liver disease: the Boston experience. JPEN J Parenter Enteral Nutr 2009, 33:541.
3. Park K.T., Nespor C., Kerner J. The use of Omegaven in treating parenteral nutrition-associated liver disease. J Perinatol 2011, 31(Suppl 1):S57-S60.
4. Moreno Villares J.M. Complicaciones hepáticas asociadas al uso de nutrición parenteral. Nutr Hosp 2008, 23(Suppl 2):25-33.
5. Lloyd D.A., Gabe S.M. Managing liver dysfunction in parenteral nutrition. Proc Nutr Soc 2007, 66:530-538.
6. Wanten G.J., Calder P.C. Immune modulation by parenteral lipid emulsions. Am J Clin Nutr 2007, 85:1171-1184.
7. Waitzberg D.L., Torrinhas R.S., Jacintho T.M. New parenteral lipid emulsions for clinical use. JPEN J Parenter Enteral Nutr 2006, 30:351-367.
8. Kumpf V.J. Parenteral nutrition-associated liver disease in adult and pediatric patients. Nutr Clin Pract 2006, 21:279-290.
9. García-de-Lorenzo A., Denia R., Atlan P., Martinez-Ratero S., Le B.A., Evard D., et al. Parenteral nutrition providing a restricted amount of linoleic acid in severely burned patients: a randomised double-blind study of an olive oil-based lipid emulsion v. medium/long-chain triacylglycerols. Br J Nutr 2005, 94:221-230.
10. Vafa H., Ballarin A., Arvanitakis M., Verrecken S., Dutat F., Lagasse C., et al. Lessons from a 20 year experience of home parenteral nutrition in adult patient. Acta Gastroenterol Belg 2010, 73:451-456.
11. Cavicchi M., Beau P., Crenn P., Degott C., Messing B. Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med 2000, 132:525-532.
12. Atkinson M., Worthley L.I. Nutrition in the critically ill patient: part I. Essential physiology and pathophysiology. Crit Care Resusc 2003, 5:109-120.
13. Miles J.M. Lipid fuel metabolism in health and disease. Curr Opin Gen Surg 1993, 78-84.
14. Smithers L.G., Gibson R.A., McPhee A., Makrides M. Effect of long-chain polyunsaturated fatty acid supplementation of preterm infants on disease risk and neurodevelopment: a systematic review of randomized controlled trials. Am J Clin Nutr 2008, 87:912-920.
15. Vanek V.W., Seidner D.L., Allen P., Bistrian B., Collier S., Gura K., et al. A.S.P.E.N. position paper: clinical role for alternative intravenous fat emulsions. Nutr Clin Pract 2012, 27:150-192.
16. Gura K.M., Duggan C.P., Collier S.B., Jennings R.W., Folkman J., Bistrian B.R., et al. Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management. Pediatrics 2006, 118:e197-e201.
17. Gura K.M., Lee S., Valim C., Zhou J., Kim S., Modi B.P., et al. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition associated liver disease. Pediatrics 2008, 121:e678-e686.
18. Puder M., Valim C., Meisel J.A., Le H.D., de Meijer V.E., Robinson E.M., et al. Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury. Ann Surg 2009, 250:395-402.
19. Diamond I.R., Sterescu A., Pnecharz P.B., Kim J.H., Wales P.W. Changing the paradigm: Omegaven for treatment of liver failure in pediatric short bowel syndrome. J Pediatr Gastroenterol Nutr 2009, 48:209-215.
20. Goulet O., Antebi H., Wolf C., Talbotec C., Alcindor L.G., Corriol O., et al. A new intravenous fat emulsion containing soybean oil, medium-chain triglycerides, olive oil, and fish oil: a single-centre, double-blind randomized study on efficacy and safety in paediatric patients receiving home parenteral nutrition. JPEN J Parenter Enteral Nutr 2010, 36:485-495.
21. Soden J.S., Lovell M.A., Brown K., Partrick D.A., Sokol R.J. Failure of resolution of portal fibrosis during omega-3 fatty acid lipid emulsion therapy in two patients with irreversible intestinal failure. J Pediatr 2010, 156:327-331.
22. Angsten G., Finkel Y., Lucas S., Kassa A.M., Paulsson M., Lilja H.E. Improved outcome in neonatal short bowel syndrome using parenteral fish oil in combination with ω-6/9 lipid emulsions. JPEN J Parenter Enteral Nutr 2012, 36:587-595.
23. Skouroliakou M., Konstantinou D., Agakidis C., Delikou N., Koutri K., Antoniadi M., et al. Cholestasis, bronchopulmonary dysplasia, and lipid profile in preterm infants receiving MCT/ω-3-PUFA-containing or soybean-based lipid emulsions. Nutr Clin Pract 2012, 27:817-824.
24. Muhammed R., Bremner R., Protheroe S., Johnson T., Holden C., Murphy M.S. Resolution of parenteral nutrition associated jaundice on changing from a soybean oil emulsion to a complex mixed-lipid emulsion. J Pediatr Gastroenterol Nutr 2012, 54:797-802.
25. Seida J.C., Mager D.R., Hartling L., Vandermeer B., Turner J.M. Parenteral ω-3 fatty acid lipid emulsions for children with intestinal failure and other conditions: a systematic review. JPEN J Parenter Enteral Nutr 2013, 37:44-55.
26. Jurewitsch B., Gardiner G., Naccarato M., Jeejeebhoy K.N. Omega-3-enriched lipid emulsion for liver salvage in parenteral nutrition-induced cholestasis in the adult patient. JPEN J Parenter Enteral Nutr 2011, 35:386-390.
27. Xu Z., Li Y., Wang J., Wu B., Li J. Effect of omega-3 polyunsaturated fatty acids to reverse biopsy-proven parenteral nutrition-associated liver disease in adults. Clin Nutr 2012, 31:217-223.
28. Venecourt-Jackson E., Hill S.J., Walmsley R.S. Successful treatment of parenteral nutrition-associated liver disease in an adult by use of a fish oil-based lipid source. Nutrition 2013, 29:356-358.
29. Burns D.L., Gill B.M. Reversal of parenteral nutrition-associated liver disease with a fish oil-based lipid emulsion (Omegaven) in an adult dependent on home parenteral nutrition. JPEN J Parenter Enteral Nutr 2013, 37:274-280.
30. Piper S.N., Schade I., Beschmann R.B., Maleck W.H., Boldt J., Röhm K.D. Hepatocellular integrity after parenteral nutrition: comparison of a fish-oil-containing lipid emulsion with an olive-soybean oil-based lipid emulsion. Eur J Anaesthesiol 2009, 26:1076-1082.
31. Zhu X., Wu Y., Qiu Y., Jiang C., Ding Y. Effects of ω-3 fish oil lipid emulsion combined with parenteral nutrition on patients undergoing liver transplantation. JPEN J Parenter Enteral Nutr 2013, 37:68-74.
32. Pawlik D., Lauterbach R., Walczak M., Hurkala J., Sherman M.P. Fish-oil fat emulsion supplementation reduces the risk of retinopathy in very low birth weight infants: a prospective, randomized study. JPEN J Parenter Enteral Nutr 2014, 38:711-716.
33. Badía-Tahull M.B., Llop-Talaverón J.M., Leiva-Badosa E., Biondo S., Farran-Teixidó L., Ramón-Torrell J.M., et al. A randomised study on the clinical progress of high-risk elective major gastrointestinal surgery patients treated with olive oil-based parenteral nutrition with or without a fish oil supplement. Br J Nutr 2010, 104:737-741.
34. Quigley E.M., Marsh M.N., Shaffer J.L., Markin R.S. Hepatobiliary complications of total parenteral nutrition. Gastroenterology 1993, 104:286-301.
35. Briones E.R., Iber F.L. Liver and biliary tract changes and injury associated with total parenteral nutrition: pathogenesis and prevention. J Am Coll Nutr 1995, 14:219-228.
36. Nauji A.A., Anderson F.H. Sensitivity and specificity of liver function tests in the detection of parenteral nutrition-associated cholestasis. JPEN J Parenter Enteral Nutr 1985, 9:307-308.
37. Kelly D.A. Liver complications of pediatric parenteral nutrition-epidemiology. Nutrition 1998, 14:153-157.
38. Abad-Lacruz A., González-Huix F., Esteve M., Fernandez-Banares F., Cabre E., Boix J., et al. Liver function tests abnormalities in patients with inflammatory bowel disease receiving artificial nutrition: a prospective randomized study of total enteral nutrition vs total parenteral nutrition. JPEN J Parenter Enteral Nutr 1990, 14:618-621.
39. Clarke P.J., Ball M.J., Kettlewell M.G. Liver function tests in patients receiving parenteral nutrition. JPEN J Parenter Enteral Nutr 1991, 15:54-59.
40. Angelico M., Della Guardia P. Review article: hepatobiliary complications associated with total parenteral nutrition. Aliment Pharmacol Ther 2000, 14(Suppl 2):54-57.
41. McClave S.A., Martindale R.G., Vanek V.W., McCarthy M., Roberts P., Taylor B., et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient. JPEN J Parenter Enteral Nutr 2009, 33:277-316.
42. Weimann A., Braga M., Harsanyi L., Laviano A., Ljungqvist O., Soeters P., et al. ESPEN Guidelines on Enteral Nutrition: surgery including organ transplantation. Clin Nutr 2006, 25:224-244.
43. Kreymanna K.G., Bergerb M.M., Deutzc N.E., Hiesmayrd M., Jolliete P., Kazandjievf G., et al. ESPEN Guidelines on Enteral Nutrition: intensive care. Clin Nutr 2006, 25:210-223.
44. Yin X., Zhao Y., Zhu X. Comparison of fast track protocol and standard care in patients undergoing elective open colorectal resection: a meta-analysis update. Appl Nurs Res 2014, 27:e20-e26.
45. Llop J., Virgili M., Moreno-Villares J.M., Garcia-Peris P., Serrano T., Forga M., et al. Phytosterolemia in parenteral nutrition patients: implications for liver disease development. Nutrition 2008, 24:1145-1152.
46. Hallay J., Olah A.V., Fulesdi B., Kocsor M., Vegh T., Kovacs G., et al. Hepatobiliary response in postoperative lipid therapy in gastrointestinal surgery. Hepatogastroenterology 2010, 57:1069-1073.
47. Heller A.R., Rössler S., Litz R.J., Stehr S.N., Heller S.C., Koch R., et al. Omega-3 fatty acids improve the diagnosis-related clinical outcome. Crit Care Med 2006, 34:972-979.
48. Cury-Boaventura M.F., Gorjão R., de Lima T.M., Piva T.M., Peres C.M., Soriano F.G., et al. Toxicity of a soybean oil emulsion on human lymphocytes and neutrophils. JPEN J Parenter Enteral Nutr 2006, 30:115-123.
49. Clayton P.T., Bowron A., Mills K.A., Massoud A., Casteels M., Milla P.J. Phytosterolemia in children with parenteral nutrition-associated cholestatic liver disease. Gastroenterology 1993, 105:1806-1813. Metabolic Disease Unit, Institute of Child Health, London, England.
50. Visschers R.G., Olde Damink S.W., Gehlen J.M., Winkens B., Soeters P.B., van Gemert W.G. Treatment of hypertriglyceridemia in patients receiving parenteral nutrition. JPEN J Parenter Enteral Nutr 2011, 35:610-615.
51. Tillman E.M. Review and clinical update on parenteral nutrition-associated liver disease. Nutr Clin Pract 2013, 28:30-39.
52. Burrin D.G., Ng K., Stoll B., De Pipaón M.S. Impact of new-generation lipid emulsions on cellular mechanisms of parenteral nutrition associated liver disease. Adv Nutr 2014, 5:82-91.
53. Iyer K.R., Spitz L., Clayton P. New insight into mechanisms of parenteral nutrition-associated cholestasis: role of plant sterols. J Pediatr Surg 1998, 33:1-6.
54. Tazuke Y., Kiristioglu I., Heidelberger K.P., Eisenbraun M.D., Teitelbaum D.H. Hepatic P-glycoprotein changes with total parenteral nutrition administration. JPEN J Parenter Enteral Nutr 2004, 28:1-6.
55. Carter B.A., Taylor O.A., Prendergast D.R., Zimmerman T.L., Von Furstenberg R., Moore D.D., et al. Stigmasterol, a soy lipid-derived phytosterol, is an antagonist of the bile acid nuclear receptor FXR. Pediatr Res 2007, 62:301-306.
56. Donner M.G., Schumacher S., Warskulat U., Heinemann J., Häussinger D. Obstructive cholestasis induces TNF-alpha- and IL-1-mediated periportal downregulation of Bsep and zonal regulation of Ntcp, Oatp 1 a4, and Oatp1 b2. Am J Physiol Gastrointest Liver Physiol 2007, 293:1134-1146.
57. Kurvinen A., Nissinen M.J., Andersson S., Korhonen P., Ruuska T., Taimisto M., et al. Parenteral plant sterols and intestinal failure-associated liver disease in neonates. J Pediatr Gastroenterol Nutr 2012, 54:803-811.